Abstract

The present disclosure relates to a novel sericin-based hydrogel for an improved treatment of wound healing, ischemic diseases or cardiovascular diseases, namely chronic wound healing, in particular diabetic wound.
The technology consists in an in-situ forming silk sericin-based hydrogel healing bio a novel wound material.
Original languageEnglish
Patent numberEP3484533
IPCA61L27/22,A61L27/52,A61L27/54,C08J3/24
Priority date12/07/16
Filing date12/07/17
Publication statusAccepted/In press - 20 Jul 2022

Fingerprint

Dive into the research topics of 'Silk sericin-based hydrogel, methods and uses thereof'. Together they form a unique fingerprint.

Cite this